Patents by Inventor Othmane Mejjad

Othmane Mejjad has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for predicting responsiveness to TNF? blocking agents
    Patent number: 7985549
    Abstract: The invention provides an in vitro method for predicting whether a patient would be responsive to a treatment with a TNF? blocking agent, which method comprises determining the expression level of eight genes in a biological sample of said patient, wherein said genes are EPS15, HLA-DPB1, AKAP9, RASGRP3, MTCBP-1, PTNP12, MRPL22 and RPS28. The invention further provides a DNA chip for performing such method.
    Type: Grant
    Filed: May 15, 2007
    Date of Patent: July 26, 2011
    Assignee: INSERM (Institut National de la Sante et de la Recherche Medicale)
    Inventors: Jean-Philippe Salier, Maryvonne Daveau, Anne-Christine Gauthier-Jauneau, Olivier Vittecoq, Xavier Le Loet, Alain Daragon, Othmane Mejjad, Thierry Lequerre
  • Method for Predicting Responsiveness to TNF Alpha Blocking Agents
    Publication number: 20090252740
    Abstract: The invention provides an in vitro method for predicting whether a patient would be responsive to a treatment with a TNF? blocking agent, which method comprises determining the expression level of eight genes in a biological sample of said patient, wherein said genes are EPS15, HLA-DPB1, AKAP9, RASGRP3, MTCBP-1, PTNP12, MRPL22 and RPS28. The invention further provides a DNA chip for performing such method.
    Type: Application
    Filed: May 15, 2007
    Publication date: October 8, 2009
    Applicant: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
    Inventors: Jean-Philippe Salier, Maryvonne Daveau, Anne-Christine Gauthier-Jauneau, Olivier Vittecoq, Xavier Le Loet, Alain Daragon, Othmane Mejjad, Thierry Lequerre